<DOC>
	<DOCNO>NCT01185977</DOCNO>
	<brief_summary>This study aim evaluate use Electroencephalography ( EEG ) biomarkers adolescent depression . Two specific hypothesis test : H1 : Early decrease prefrontal cordance value great responder antidepressant therapy medication non-responders . H2 : Subjects high Antidepressant Treatment Response ( ATR ) Index value [ i.e. , predict show symptomatic improvement fluoxetine ( FLX ) ] achieve great improvement symptom functional status low ATR value . Exploratory analyse undertaken compare contrast cordance change ATR value medication placebo-treated responder non-responders .</brief_summary>
	<brief_title>Biomarkers Antidepressant Treatment Adolescents With Major Depression ( The Adolescents MDD Study )</brief_title>
	<detailed_description>A total 26 adolescent subject Major Depressive Disorder ( MDD ) , age 12 20 , consent join project UCLA . For analytic purpose , define `` enrol '' subject one complete single-blind lead-in week one week double-blind treatment , three EEG recording visit , subject leaf project prior point contribute useful data test hypothesis . Subjects enroll project receive 1 week single-blind placebo lead-in , follow 8 week double-blind randomized treatment either fluoxetine ( FLX ) , Selective Serotonin Reuptake Inhibitor ( SSRI ) FDA approval use age group , placebo . Brain activity assess Qualitative EEG ( QEEG ) record pretreatment baseline , lead-in , 1 , 2 , 4 , 8 week treatment expand evidence base neurophysiology treatment response adolescent . Subjects assess symptom change , adverse event , suicidality visit . Functional measure relate treatment assess baseline week 4 8 . Subjects staff interact blind QEEG biomarker value project .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Outpatients nonpsychotic , unipolar Major Depressive Disorder ( MDD ) base KSADSPL A score ≥ 45 Children 's Depression Rating ScaleRevised ( threshold TADS ) . As TADS trial , depress mood must present least 2 3 context ( home , school , among peer ) least 6 week prior consent . Age range : 1418 . Patients suicidal ideation eligible thought death life worth live accompanied plan intention selfharm . Subjects unstable medical illness would prevent completion participation trial ( determine need physical examination , ECG , laboratory safety test , well review system ) . Other specific exclusionary criterion also base BRITEMD parameter , include : 1. mentally legally incapacitate , unable give inform consent ; 2. meet DSMIV criterion anorexia nervosa , bulimia nervosa , obsessivecompulsive disorder , cognitive disorder , bipolar disorder , psychotic disorder , major depression psychotic feature ; 3 . MMSE ( Folstein et al. , 1975 ) score ≤ 24 ; 4. evidence drug dependency substance abuse within precede nine month ; 5. stable remission current psychotropic medication ( ) ; 6. ECT within past six month ; 7. failure tolerate FLX treatment failure adequate trial FLX current episode ; 8 . FLX would contraindicate ( e.g. , hyponatremia prior SSRI ) ; 9. treatment MAOI within past four week ; 10. medical illness severe enough significantly affect brain function interfere interpretation study result ; 11. history seizure , brain surgery , skull fracture , significant head trauma , abnormal EEG ; 12. psychiatric hospitalization indicate ( e.g. , imminent danger self others ) ; 13. initial QEEG recording contaminate artifact determination biomarker preclude ; 14. use medication know affect brain function ( e.g. , antidepressant , anticonvulsants/mood stabilizer , anticholinergic , antipsychotic , benzodiazepine list BRITEMD ) . Based TADS trial , also exclude concurrent diagnosis attentiondeficit hyperactivity disorder manage psychostimulants , pervasive developmental disorder , mental retardation ( mild , moderate , severe , profound ) ; 15. subject currently pregnant , childbearing potential use medically acceptable mean birth control ( defined oral contraceptive pill implant , condom , diaphragm , spermicide , IUD , s/p tubal ligation , partner vasectomy ) .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Fluoxetine</keyword>
	<keyword>QEEG</keyword>
	<keyword>cordance</keyword>
	<keyword>ATR</keyword>
</DOC>